ambisome liposomal amphotericin b 50 milligram concentrate for soln for inf
gilead sciences international - amphotericin b - concentrate for soln for inf - 50 milligram - antibiotics
truvada
gilead sciences israel ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - truvada is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk .
truvada
gilead sciences israel ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - truvada is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk .
truvada
gilead sciences israel ltd - emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - tenofovir disoproxil - tenofovir disoproxil - truvada is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.truvada is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk .
yescarta
gilead sciences israel ltd - axicabtagene ciloleucel - dispersion for infusion - axicabtagene ciloleucel - yescarta is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy.yescarta is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and primary mediastinal large b-cell lymphoma (pmbcl), after two or more lines of systemic therapy. limitation of use :yescarta is not indicated for the treatment of patients with primary or secondary central nervous system lymphoma.yescarta is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy
tecartus
gilead sciences israel ltd - anti-cd19 car t cells - dispersion for infusion - anti-cd19 car t cells - acute lymphoblastic leukaemia tecartus is indicated for the treatment of adult patients with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).mantle cell lymphoma tecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton's tyrosine kinase (btk) inhibitor unless ineligible to btk inhibitor •limitation of use : tecartus is not indicated for the treatment of patients with active central nervous system lymphoma
stribild 150mg150mg200mg245mg tablets
gilead sciences international ltd - tenofovir disoproxil fumarate; emtricitabine; cobicistat; elvitegravir - tablet - 245mg ; 200mg ; 150mg ; 150mg
tybost 150mg tablets
gilead sciences international ltd - cobicistat - tablet - 150mg
harvoni 90mg400mg tablets
gilead sciences international ltd - ledipasvir; sofosbuvir - tablet - 90mg ; 400mg
genvoya 150mg150mg200mg10mg tablets
gilead sciences international ltd - tenofovir alafenamide; emtricitabine; cobicistat; elvitegravir - tablet - 10mg ; 200mg ; 150mg ; 150mg